Centessa Pharmaceuticals (CNTA) News Today → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free CNTA Stock Alerts $8.93 -0.53 (-5.60%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineCentessa: Hemophilia B Data Readout In 2024 Is Major Turning Pointseekingalpha.com - April 24 at 4:47 PMCentessa Pharmaceuticals (NASDAQ:CNTA) Sees Large Volume Increasemarketbeat.com - April 24 at 3:36 PMCentessa Pharma Prices Public Offering Of About 10.81 Mln ADSs At $9.25/ADSnasdaq.com - April 24 at 1:35 AMCentessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Sharesglobenewswire.com - April 23 at 9:36 PMCentessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Sharesglobenewswire.com - April 23 at 4:17 PMCentessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Down 3.3%marketbeat.com - April 23 at 3:44 PMCentessa Pharmaceuticals (NASDAQ:CNTA) Shares Gap Up to $10.57marketbeat.com - April 22 at 12:49 PMCentessa Gains on New Product Newsbaystreet.ca - April 22 at 10:49 AMCentessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024globenewswire.com - April 22 at 7:00 AMCentessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Down 5.3%marketbeat.com - April 12 at 2:51 PMBuy Rating Affirmed for Centessa Pharmaceuticals Amid Promising ORX750 Prospects and Favorable Trial Resultsmarkets.businessinsider.com - April 12 at 8:16 AMCentessa Pharmaceuticals (NASDAQ:CNTA) Trading Up 6.3%marketbeat.com - April 11 at 4:01 PMCentessa Pharmaceuticals (NASDAQ:CNTA) Shares Gap Up to $10.37marketbeat.com - April 8 at 11:36 AMCentessa Pharmaceuticals (NASDAQ:CNTA) Trading Down 3.6%marketbeat.com - April 1 at 2:59 PMCentessa Pharmaceuticals plc (NASDAQ:CNTA) Receives Average Recommendation of "Moderate Buy" from Brokeragesmarketbeat.com - April 1 at 2:31 PMBMO Capital Markets Reiterates Outperform Rating for Centessa Pharmaceuticals (NASDAQ:CNTA)marketbeat.com - April 1 at 1:38 PMCNTA Stock Earnings: Centessa Pharmaceuticals Beats EPS for Q4 2023msn.com - March 29 at 12:00 AMCentessa Pharmaceuticals plc: Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023finanznachrichten.de - March 28 at 6:59 PMCentessa Pharmaceuticals PLC (CNTA) Earnings: A Detailed Look at Q4 and Full-Year 2023 Resultsfinance.yahoo.com - March 28 at 6:59 PMCentessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023globenewswire.com - March 28 at 4:28 PMCentessa Pharmaceuticals PLC Chief People Officer Sells Company Sharesfinance.yahoo.com - March 27 at 10:24 AMInsider Selling: Centessa Pharmaceuticals plc (NASDAQ:CNTA) Insider Sells 51,160 Shares of Stockinsidertrades.com - March 27 at 5:09 AMCentessa Pharmaceuticals plc (NASDAQ:CNTA) Insider Karen M. Anderson Sells 51,160 Sharesmarketbeat.com - March 26 at 6:41 PM7 Biotech Stocks Ready to Ride the Sector’s Resurgencefinance.yahoo.com - March 26 at 5:55 AMCentessa Pharmaceuticals (NASDAQ:CNTA) Trading Down 5.6%marketbeat.com - March 25 at 6:40 PMCentessa Pharmaceuticals (NASDAQ:CNTA) Reaches New 52-Week High at $12.41marketbeat.com - March 21 at 10:47 AMCentessa Pharmaceuticals PLC ADRwsj.com - March 20 at 11:10 PMCentessa Pharmaceuticals PLC ADR (CNTA)investing.com - March 19 at 8:52 AM7 Biotech Stocks Ready to Ride the Sector's Resurgenceinvestorplace.com - March 18 at 8:01 PMCNTA Apr 2024 7.500 putfinance.yahoo.com - March 16 at 3:43 PMCNTA Apr 2024 5.000 callfinance.yahoo.com - March 16 at 10:43 AMCNTA Jul 2024 7.500 putfinance.yahoo.com - March 16 at 10:43 AMPrivate equity firms who have a significant stake must be disappointed along with institutions after Centessa Pharmaceuticals plc's (NASDAQ:CNTA) market cap dropped by US$139mfinance.yahoo.com - March 12 at 6:13 PMCentessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Up 6.7%marketbeat.com - March 12 at 1:24 PMCentessa Pharmaceuticals (NASDAQ:CNTA) Stock Price Down 4%marketbeat.com - March 11 at 11:53 AMAdage Capital Partners GP L.L.C. Purchases 580,500 Shares of Centessa Pharmaceuticals plc (NASDAQ:CNTA)marketbeat.com - March 8 at 7:19 AMUpgraded Buy Rating and Price Target for Centessa Pharmaceuticals on SerpinPC’s Market Potentialmarkets.businessinsider.com - March 7 at 9:30 AMLeerink Partnrs Research Analysts Lower Earnings Estimates for Centessa Pharmaceuticals plc (NASDAQ:CNTA)marketbeat.com - March 7 at 7:37 AMLeerink Partnrs Weighs in on Centessa Pharmaceuticals plc's Q1 2024 Earnings (NASDAQ:CNTA)marketbeat.com - March 6 at 7:47 AMAcuta Capital Partners LLC Acquires New Shares in Centessa Pharmaceuticals plc (NASDAQ:CNTA)marketbeat.com - March 3 at 12:18 PMCentessa Pharmaceuticals to Participate in TD Cowen’s 44th Annual Health Care Conferencefinance.yahoo.com - February 22 at 10:10 AMCentessa Pharmaceuticals (NASDAQ:CNTA) Trading Up 9%marketbeat.com - February 16 at 3:53 PMCNTA Centessa Pharmaceuticals plcseekingalpha.com - February 15 at 6:17 PMCentessa Pharmaceuticals (NASDAQ:CNTA) Hits New 52-Week High at $10.55marketbeat.com - February 15 at 10:45 AMCentessa Pharmaceuticals plc (NASDAQ:CNTA) Sees Significant Decrease in Short Interestmarketbeat.com - February 15 at 7:24 AMCentessa Pharmaceuticals Stock (NASDAQ:CNTA) Dividends: History, Yield and Datesbenzinga.com - February 14 at 10:09 AMCentessa Pharmaceuticals Unveils Clinical Data Onlinemarkets.businessinsider.com - February 10 at 9:28 AMCentessa Pharmaceuticals (NASDAQ:CNTA) Hits New 12-Month High at $9.40marketbeat.com - February 9 at 12:21 PMCentessa Pharmaceuticals to Present Additional 52-Weeks of Continuous Treatment Data from Third Year (Part 5) of Ongoing Phase 2a Study of SerpinPC for the Treatment of Hemophilia at the 17th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)finance.yahoo.com - February 9 at 9:35 AMCentessa Pharmaceuticals: Clinical Advances And Unique Business Model Highlight Growth Potentialseekingalpha.com - February 5 at 5:49 PM Get Centessa Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CNTA and its competitors with MarketBeat's FREE daily newsletter. Email Address “Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers. Find out why right here (and see what you can do to get in too with just a few dollars). CNTA Media Mentions By Week CNTA Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CNTA News Sentiment▼0.190.41▲Average Medical News Sentiment CNTA News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CNTA Articles This Week▼102▲CNTA Articles Average Week Get Centessa Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CNTA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: IMNM News MNKD News SRRK News MIRM News PRTA News XNCR News OCUL News COLL News BLTE News MGNX News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CNTA) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersI’m afraid WWIII is a very real possibility Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Centessa Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
